Raras
Buscar doenças, sintomas, genes...
Uveíte
ORPHA:98715DOENÇA RARA

É uma inflamação que atinge uma parte ou toda a úvea do olho. Pode ser causada por infecções (como herpes simples, herpes zoster, leptospirose) e por doenças que afetam o corpo todo (como doença inflamatória intestinal, esclerose múltipla, lúpus eritematoso sistêmico, espondilite anquilosante). Os pacientes apresentam dor e vermelhidão no olho, sensibilidade à luz e visão embaçada e dificuldade para enxergar.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma inflamação que atinge uma parte ou toda a úvea do olho. Pode ser causada por infecções (como herpes simples, herpes zoster, leptospirose) e por doenças que afetam o corpo todo (como doença inflamatória intestinal, esclerose múltipla, lúpus eritematoso sistêmico, espondilite anquilosante). Os pacientes apresentam dor e vermelhidão no olho, sensibilidade à luz e visão embaçada e dificuldade para enxergar.

Pesquisas ativas
18 ensaios
510 total registrados no ClinicalTrials.gov
Publicações científicas
25.838 artigos
Último publicado: 2026 Apr 17

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
38.0
Europe
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
57 sintomas
🧠
Neurológico
13 sintomas
😀
Face
7 sintomas
🧬
Pele e cabelo
7 sintomas
🦴
Ossos e articulações
5 sintomas
👂
Ouvidos
4 sintomas

+ 61 sintomas em outras categorias

Características mais comuns

Anormalidade da visão
Aplasia/Hipoplasia do cerebelo
Estreitamento biparietal
Escoliose
Atrofia cortical cerebral
Estrabismo
162sintomas
Sem dados (162)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 162 características clínicas mais associadas, ordenadas por frequência.

Anormalidade da visãoAbnormality of vision
Aplasia/Hipoplasia do cerebeloAplasia/Hypoplasia of the cerebellum
Estreitamento biparietalBiparietal narrowing
EscolioseScoliosis
Atrofia cortical cerebralCerebral cortical atrophy

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico25.838PubMed
Últimos 10 anos200publicações
Pico2026197 papers
Linha do tempo
2026Hoje · 2026🧪 1986Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

7 genes identificados com associação a esta condição.

TUBGCP6Gamma-tubulin complex component 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the gamma-tubulin ring complex (gTuRC) which mediates microtubule nucleation (PubMed:11694571, PubMed:38305685, PubMed:38609661, PubMed:39321809). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (PubMed:38305685, PubMed:38609661, PubMed:39321809)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
Recruitment of mitotic centrosome proteins and complexesRecruitment of NuMA to mitotic centrosomes
MECANISMO DE DOENÇA

Microcephaly and chorioretinopathy, autosomal recessive, 1

A syndrome characterized by microcephaly, cognitive impairment, underdeveloped retina and choroid, and epilepsy in some patients. The more anterior parts of the retina, near the periphery and pars plana, have a grayish hue and diminutive vasculature similar to retinopathy of prematurity. Visual impairment becomes evident during the first year of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
124.7 TPM
Cérebro - Hemisfério cerebelar
109.4 TPM
Tireoide
83.5 TPM
Pituitária
80.3 TPM
Cervix Endocervix
66.9 TPM
OUTRAS DOENÇAS (1)
microcephaly and chorioretinopathy 1
HGNC:18127UniProt:Q96RT7
HLA-AHLA class I histocompatibility antigen, A alpha chainCandidate gene tested inTolerante
FUNÇÃO

Antigen-presenting major histocompatibility complex class I (MHCI) molecule. In complex with B2M/beta 2 microglobulin displays primarily viral and tumor-derived peptides on antigen-presenting cells for recognition by alpha-beta T cell receptor (TCR) on HLA-A-restricted CD8-positive T cells, guiding antigen-specific T cell immune response to eliminate infected or transformed cells (PubMed:10449296, PubMed:12138174, PubMed:12393434, PubMed:1402688, PubMed:15893615, PubMed:17189421, PubMed:19543285

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
E3 ubiquitin ligases ubiquitinate target proteins
EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
3020.0 TPM
Linfócitos
2770.5 TPM
Baço
2431.7 TPM
Pulmão
1955.9 TPM
Intestino delgado
1462.0 TPM
OUTRAS DOENÇAS (2)
birdshot chorioretinopathyStevens-Johnson syndrome
HGNC:4931UniProt:P04439
PTPN22Tyrosine-protein phosphatase non-receptor type 22Candidate gene tested inTolerante
FUNÇÃO

Acts as a negative regulator of T-cell receptor (TCR) signaling by direct dephosphorylation of the Src family kinases LCK and FYN, ITAMs of the TCRz/CD3 complex, as well as ZAP70, VAV, VCP and other key signaling molecules (PubMed:16461343, PubMed:18056643). Associates with and probably dephosphorylates CBL. Dephosphorylates LCK at its activating 'Tyr-394' residue (PubMed:21719704). Dephosphorylates ZAP70 at its activating 'Tyr-493' residue (PubMed:16461343). Dephosphorylates the immune system a

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (2)
Phosphorylation of CD3 and TCR zeta chainsTranslocation of ZAP-70 to Immunological synapse
MECANISMO DE DOENÇA

Systemic lupus erythematosus

A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
50.6 TPM
Baço
13.9 TPM
Sangue
12.7 TPM
Intestino delgado
9.6 TPM
Pulmão
8.7 TPM
OUTRAS DOENÇAS (6)
systemic lupus erythematosusVogt-Koyanagi-Harada diseaseoligoarticular juvenile idiopathic arthritisrheumatoid factor-negative juvenile idiopathic arthritis
HGNC:9652UniProt:Q9Y2R2
HLA-DRB1HLA class II histocompatibility antigen, DRB1 beta chainCandidate gene tested inRestrito
FUNÇÃO

A beta chain of antigen-presenting major histocompatibility complex class II (MHCII) molecule. In complex with the alpha chain HLA-DRA, displays antigenic peptides on professional antigen presenting cells (APCs) for recognition by alpha-beta T cell receptor (TCR) on HLA-DRB1-restricted CD4-positive T cells. This guides antigen-specific T-helper effector functions, both antibody-mediated immune response and macrophage activation, to ultimately eliminate the infectious agents and transformed cells

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneLysosome membraneLate endosome membraneAutolysosome membrane

VIAS BIOLÓGICAS (7)
Generation of second messenger moleculesTranslocation of ZAP-70 to Immunological synapsePhosphorylation of CD3 and TCR zeta chainsCo-inhibition by PD-1Downstream TCR signaling
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
1832.6 TPM
Pulmão
1234.8 TPM
Baço
990.6 TPM
Intestino delgado
607.2 TPM
Nervo tibial
598.3 TPM
OUTRAS DOENÇAS (16)
narcolepsy-cataplexy syndromefollicular lymphomaVogt-Koyanagi-Harada diseasepediatric multiple sclerosis
HGNC:4948UniProt:P01911
FASTumor necrosis factor receptor superfamily member 6Candidate gene tested inAltamente restrito
FUNÇÃO

Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase CASP8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs CASP8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in v

LOCALIZAÇÃO

Cell membraneMembrane raftSecreted

VIAS BIOLÓGICAS (7)
RIPK1-mediated regulated necrosisCASP8 activity is inhibitedRegulation by c-FLIPCaspase activation via Death Receptors in the presence of ligandDimerization of procaspase-8
MECANISMO DE DOENÇA

Autoimmune lymphoproliferative syndrome 1A

A disorder of apoptosis that manifests in early childhood and results in the accumulation of autoreactive lymphocytes. It is characterized by non-malignant lymphadenopathy with hepatosplenomegaly, and autoimmune hemolytic anemia, thrombocytopenia and neutropenia.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
75.4 TPM
Ovário
43.2 TPM
Fibroblastos
41.0 TPM
Pulmão
37.9 TPM
Cervix Endocervix
28.8 TPM
OUTRAS DOENÇAS (4)
autoimmune lymphoproliferative syndrome type 1Vogt-Koyanagi-Harada diseaseBehcet diseaseautoimmune lymphoproliferative syndrome
HGNC:11920UniProt:P25445
TUBGCP4Gamma-tubulin complex component 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the gamma-tubulin ring complex (gTuRC) which mediates microtubule nucleation (PubMed:38305685, PubMed:38609661, PubMed:39321809). The gTuRC regulates the minus-end nucleation of alpha-beta tubulin heterodimers that grow into microtubule protafilaments, a critical step in centrosome duplication and spindle formation (PubMed:38305685, PubMed:38609661, PubMed:39321809)

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (2)
Recruitment of mitotic centrosome proteins and complexesRecruitment of NuMA to mitotic centrosomes
MECANISMO DE DOENÇA

Microcephaly and chorioretinopathy, autosomal recessive, 3

A disorder characterized by congenital microcephaly and chorioretinal dysplasia associated with poor vision and nystagmus. Variable ocular anomalies include microphthalmia, retinal folding, retinal detachment, optic nerve hypoplasia, absence of retinal vessels, round areas of chorioretinal atrophy, and attenuated electroretinogram. Most patients have mild developmental delay and mild learning difficulties.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
23.8 TPM
Cerebelo
20.9 TPM
Linfócitos
16.1 TPM
Cervix Ectocervix
12.7 TPM
Cervix Endocervix
12.6 TPM
OUTRAS DOENÇAS (2)
microcephaly and chorioretinopathy 3microcephaly and chorioretinopathy 1
HGNC:16691UniProt:Q9UGJ1
PLK4Serine/threonine-protein kinase PLK4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Serine/threonine-protein kinase that plays a central role in centriole duplication. Able to trigger procentriole formation on the surface of the parental centriole cylinder, leading to the recruitment of centriole biogenesis proteins such as SASS6, CPAP, CCP110, CEP135 and gamma-tubulin. When overexpressed, it is able to induce centrosome amplification through the simultaneous generation of multiple procentrioles adjoining each parental centriole during S phase. Phosphorylates 'Ser-151' of FBXW5

LOCALIZAÇÃO

Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleNucleus, nucleolusCleavage furrowCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (7)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Microcephaly and chorioretinopathy, autosomal recessive, 2

A severe disorder characterized by microcephaly, delayed psychomotor development, growth retardation with dwarfism, and ocular abnormalities.

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
29.8 TPM
Testículo
24.2 TPM
Fibroblastos
6.7 TPM
Esôfago - Mucosa
4.5 TPM
Skin Not Sun Exposed Suprapubic
2.8 TPM
OUTRAS DOENÇAS (3)
microcephaly and chorioretinopathy 2Seckel syndromemicrocephaly and chorioretinopathy 1
HGNC:11397UniProt:O00444

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 PredniSONE (PREDNISONE)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

396 variantes patogênicas registradas no ClinVar.

🧬 TUBGCP6: NM_020461.4(TUBGCP6):c.1929C>A (p.Tyr643Ter) ()
🧬 TUBGCP6: NM_020461.4(TUBGCP6):c.4620dup (p.Glu1541Ter) ()
🧬 TUBGCP6: NM_020461.4(TUBGCP6):c.34dup (p.Cys12fs) ()
🧬 TUBGCP6: NM_020461.4(TUBGCP6):c.670del (p.Tyr224fs) ()
🧬 TUBGCP6: NM_020461.4(TUBGCP6):c.4315+2T>C ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
3Fase 32
2Fase 23
1Fase 12
·Pré-clínico13
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Uveíte

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

510 ensaios clínicos encontrados, 18 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
11.889 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 11.889

#1

Quantitative Assessment of Fluorescein Angiography Leakage via Deep Learning in Pediatric Uveitis: Correlation with Clinical Parameters.

Ophthalmology science2026 Apr

Develop a deep learning algorithm for automated segmentation of retinal vascular and macular edema (ME) leakage in fluorescein angiography (FA) of pediatric uveitis. Model trained on internal FA images with external validation. One hundred eighty-three pediatric uveitis patients (3144 FA images) at the Eye Hospital of Wenzhou Medical University. External validation used 45 patients (396 FA images) from The First Affiliated Hospital of Soochow University and The Affiliated Eye Hospital of Nanjing Medical University. The model was trained, validated, and applied to 28 independent pediatric cases to correlate leakage area with clinical metrics and determine clinically significant change thresholds. Segmentation performance (Dice) and pixel-based leakage area for analysis. In fivefold cross-validation on 2459 internal images (155 patients), the best mean Dice scores were 0.7241 (retinal leakage) and 0.7273 (macular leakage). On external data, the best mean Dice reached 0.7015 and 0.5918, respectively. In the cohort of 28 pediatric uveitis patients, vitreous cells (VCs) and central macular thickness (CMT) were the most consistent parameters associated with retinal leakage across multiple analyses. After multiple comparison correction, both VC and CMT remained significantly associated with total and posterior pole leakage areas at all time points. For ME leakage, CMT and best-corrected visual acuity showed consistent associations, while VC was significant only at follow-up, whereas other examined variables showed no consistent association after correction for multiple comparisons. Receiver operating characteristic analysis identified a -54.8% relative change in total visible retinal leakage area as the optimal cutoff, indicating quiescent inflammation. The deep learning model reliably segments leakage in pediatric uveitis FA, showing multicenter generalizability. Quantitative angiographic parameters correlate with clinical metrics, suggesting potential utility for informing disease management strategies. The author has no/the authors have no proprietary or commercial interest in any materials discussed in this article.

#2

OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.

Ophthalmology science2026 Apr

To evaluate OCT vitreous signal intensity (OCT-VI) as a biomarker of vitreous haze (VH) in a longitudinal, prospective, and standardized manner in the First-Line Antimetabolites as Steroid-Sparing Treatment (FAST) Uveitis Trial. Secondary analysis of a block-randomized, observer-masked, multicenter clinical trial. Two hundred sixty-seven eyes from 147 patients with uveitis enrolled in the FAST Trial were evaluated in this analysis at baseline (BL), month 6 (M6), and month 12 (M12). For each patient, Heidelberg Spectralis OCT volume scans (Heidelberg Engineering) were imported into the Doheny Reading Center 3D-OCTOR software and underwent a semi-automated segmentation. For each OCT volume, 5 B-scans were used to calculate the OCT-VI as a ratio of the vitreous space to the entire image. OCT vitreous signal intensity at BL, M6, and M12 visits and the association with the National Eye Institute VH scale, anterior chamber (AC) cell grade, posterior synechiae (PS), lens status, visual acuity (VA), and central macular thickness (CMT). At BL, the median relative vitreous intensity was 0.43 (interquartile range, [0.33-0.54]) and reduced to 0.39 (0.27-0.53) at M6 and 0.39 (0.26-0.54) at M12. A mixed-effects linear regression model showed that OCT-VI and VH clinical grades were statistically significantly correlated (P < 0.001) when controlled for age, sex, time points, and eye. A statistically significant decrease of OCT-VI was observed over time with treatment (P < 0.001). A 2-step grade decrease in VH was associated with a -0.07 (standard deviation 0.19) change in OCT-VI. A mixed-effects linear regression model demonstrated a statistically significant association between OCT-VI and VA (b = 0.170, P = 0.020). A higher OCT-VI was associated with increasing grades of AC cell (P < 0.001) and presence of cataract (P < 0.001). There was no significant association (P > 0.05) of OCT-VI with PS or CMT. In the FAST Uveitis Trial, OCT-VI was significantly correlated with the VH clinical grades and demonstrated significant longitudinal changes. OCT vitreous signal intensity may serve as a potential objective biomarker of VH. Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

#3

Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation.

Molecular therapy : the journal of the American Society of Gene Therapy2026 Mar 13

Inflammation elicited by rAAV vectors continues to present a critical challenge for long-term efficacy and safety of gene therapy in the eye. Preclinical models of gene therapy-associated uveitis (GTAU) show that despite resolution of early acute inflammatory response, persistent subclinical inflammation remains. Here, we employ the GTAU model in Cx3cr1CreER:R26-tdTomato+/- mice to reveal that intravitreal (IVT) rAAV2 administration elicits sustained microglial dysregulation and retention of CD3+ T cells extending to 50 days post-injection (dpi). Deploying pharmacological and genetic approaches, we define the absolute requirement for microglia and T cells to mediate rAAV2-induced inflammation. Targeted depletion confirmed microglia-independent mechanisms initiate GTAU, whilst elimination of lymphocytes prevented both inflammation and microglial activation. Systematic evaluation of therapeutic strategies reveals identified inhibition of T cell recruitment via sphingosine-1-phosphate receptor modulation, but not B cell depletion, as an effective steroid-sparing strategy to prevent both acute and long-term subclinical inflammation. Collectively, our findings challenge the paradigm of microglia-driven ocular inflammation and support the utility of targeted T cell immunomodulation strategies to control GTAU and maintain long-term ocular homeostasis.

#4

Focus on Lactate and Lactylation Modification: The Potential Role in Ophthalmic Disease Treatment.

International journal of molecular sciences2026 Mar 09

Lysine lactylation represents a novel post-translational modification (PTM) involved in cellular functions including glycolysis and macrophage polarisation. It differs in form and mechanism from other PTMs such as acetylation, methylation, phosphorylation, ubiquitination, and SUMOylation. As a recently discovered modification, lactylation has been implicated in the progression of multiple diseases. Recent studies further indicate lactylation's association with multiple ocular pathologies. This review systematically summarises and discusses lactylation's involvement in prevalent eye diseases, including myopia, retinopathy, ocular melanoma, uveitis, and macular degeneration. We further collate emerging data suggesting lactylation signalling pathways may represent potential therapeutic targets for ocular pathologies. This review aims to provide a comprehensive overview for holistic intervention strategies and multidimensional assessment across various ocular conditions, while offering valuable insights for future research and development from a lactylation perspective.

#5

Visual Disturbance and Elevated Glutamic Acid Decarboxylase Antibody Levels as Manifestations of Central Nervous System Lymphoma.

Neurology India2026 Mar 01

Various neurologic manifestations are observed in the course of hematologic malignancies. Clinical neurologic symptoms and manifestations of malignancies may result from the malignancy itself, inflammatory responses, or paraneoplastic syndromes. Therefore, differential diagnosis on the basis of clinical presentation is challenging. This is the first study to report a patient with central nervous system lymphoma and elevated glutamic acid decarboxylase antibody levels who presented with uveitis masquerade syndrome (UMS), followed by progressive consciousness change, mimicking autoimmune encephalitis.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC12.898 artigos no totalmostrando 196

2026

The Immunopathogenesis of uveitis.

Frontiers in medicine
2026

Vitreoretinal Myeloid Cell Heterogeneity: Diverse Roles in Homeostasis, Immune Surveillance, and Pathophysiology.

Journal of immunology (Baltimore, Md. : 1950)
2026

EULAR recommendations for the management of Behçet's syndrome: 2025 update.

Annals of the rheumatic diseases
2026

[Noninfectious uveitis in childhood : Clinical aspects, diagnostics, treatment and transition].

Die Ophthalmologie
2026

CHARACTERIZING INTRAOCULAR LENS POSITION, STABILITY, AND IRIS MOBILITY IN EYES THAT HAVE UNDERGONE SUTURELESS INTRASCLERAL HAPTIC FIXATION.

Retina (Philadelphia, Pa.)
2026

The Association Between Uveitis and Optic Neuritis in Central Nervous System Demyelinating Disorders: A Multi-Institutional Cohort Study.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2026

A triamcinolone acetonide palmitate nanoemulsion eye drop delivered by iontophoresis for the management of posterior uveitis.

International journal of pharmaceutics
2026

Long-Term Follow Up of Presumed Trematode Induced Granulomatous Intermediate Uveitis: Predictors for Failure of Medical Treatment.

Ocular immunology and inflammation
2026

Case Report: Maculopathy following standard dose intracameral cefuroxime injection during ICL surgery.

Frontiers in ophthalmology
2026

Clinical characteristics and quality of life measures in children with glaucoma-suspect or glaucoma diagnoses in chronic, noninfectious uveitis.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2026

Laser peripheral iridotomy for treating recurrent uveitis-glaucoma-hyphema plus syndrome with a scleral fixed intraocular lens: a case report.

BMC ophthalmology
2026

Imaging Measures for the Assessment of Disease Activity in Non-Infectious Posterior Uveitis - Multimodal Imaging in Uveitis (MUV) Taskforce: Report 10.

American journal of ophthalmology
2026

NON-INFECTIOUS POSTERIOR UVEITIDES - Atypicals, Variants, and Masquerades: the jungle of differential diagnosis.

American journal of ophthalmology
2026

Blau syndrome with atrophoderma vermiculata-like appearance: a case report.

Frontiers in immunology
2026

Quantitative Assessment of Fluorescein Angiography Leakage via Deep Learning in Pediatric Uveitis: Correlation with Clinical Parameters.

Ophthalmology science
2026

Rheumatic diseases in childhood: Clinical and immunological characteristics of a pediatric cohort at a tertiary hospital.

Reumatologia clinica
2026

Single-centre observational study of anti-adalimumab antibody development in children and young people treated for juvenile idiopathic arthritis and/or non-infectious uveitis.

The British journal of ophthalmology
2026

The Multimodal Imaging in Uveitis Virtual Special Issue.

American journal of ophthalmology
2026

Ocular Complications of Cosmetic Laser Use in Patients and Treating Doctors/Estheticians: A Systematic Review of Case Reports and Case Series.

Indian dermatology online journal
2026

OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.

Ophthalmology science
2026

Subretinal parasitic lesion mimicking viral retinitis managed with combined medical therapy and laser photocoagulation.

IDCases
2026

Sarcoid Uveitis with Choroidal Involvement.

Clinical ophthalmology (Auckland, N.Z.)
2026

Tislelizumab-induced Vogt-Koyanagi-Harada-like uveitis: a case report.

BMC ophthalmology
2026

Immune checkpoints in a genetically engineered mouse model of spontaneous autoimmune uveitis.

Journal of immunology (Baltimore, Md. : 1950)
2026

Correlation Between SUN Scale Grades and AS-OCT Cell Counts in Pediatric Uveitis: A Retrospective Central 7-Frame Analysis.

Clinical ophthalmology (Auckland, N.Z.)
2026

Characterisation of Ocular Manifestations in Patients with Multiple Sclerosis in Colombia: A Multicentric Study.

Neuro-ophthalmology (Aeolus Press)
2026

Long-Term Efficacy and Safety of Adalimumab in Pediatric Non-Infectious Uveitis: Including Weekly Dosing Escalation in Refractory Cases.

Ocular immunology and inflammation
2026

Uveitis of undifferentiated etiology: insights into diagnosis and evolution from a cohort of 338 patients.

BMC ophthalmology
2026

Transient pseudotumoral inflammatory angle mass in HLA-B27 acute anterior uveitis.

Eye (London, England)
2026

Targeted Management of Uveitis-Glaucoma-Hyphema Syndrome by Selective Haptic Removal: A Case Report.

Klinische Monatsblatter fur Augenheilkunde
2026

Hypertensive Uveitis After Intravitreal Faricimab: Clinical and Methodological Considerations.

Clinical &amp; experimental ophthalmology
2026

How to interpret low-dose valacyclovir for postherpetic neuralgia in the Zoster Eye Disease Study-a randomized clinical trial.

Annals of translational medicine
2026

Choroidal Osteoma with Focal Choroidal Excavation Masquerading as Active Vogt-Koyanagi-Harada: A Case Report.

Case reports in ophthalmology
2026

Relapsing Intermediate Uveitis following Resolved Syphilitic Retinitis in an HIV-Positive Patient: A Case Report.

Case reports in ophthalmology
2026

Clinical Correlates of a successful transition in Pediatric Rheumatology.

The Journal of rheumatology
2026

Ocular adverse events associated with aflibercept and faricimab: a population-based pharmacovigilance study.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2026

Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation.

Molecular therapy : the journal of the American Society of Gene Therapy
2026

Focus on Lactate and Lactylation Modification: The Potential Role in Ophthalmic Disease Treatment.

International journal of molecular sciences
2026

Prevalence of Comorbidities in Inflammatory Bowel Disease: An Umbrella Review of 18 Systematic Reviews.

Journal of clinical medicine
2026

Iris Vascular Characteristics Changes in Non-Infectious Uveitis: A Wide-Field Swept-Source Anterior Segment Optical Coherence Tomography Angiography Study.

Ocular immunology and inflammation
2026

Combined PCR Positivity for Mycobacterium tuberculosis Complex and Nontuberculous Mycobacterium Species in Patients Treated for Tubercular Panuveitis.

Ocular immunology and inflammation
2026

Zoledronic Acid Associated Anterior Uveitis - A Single Institutional Experience on Management and the Rechallenge.

Ocular immunology and inflammation
2026

Incidence and Prevalence of Depression, Anxiety, and Suicidal Ideation in Patients with Uveitis and Scleritis in the TriNetX Database.

Ocular immunology and inflammation
2026

Uveitis Associated with Protein Kinase Inhibitors in Cancer Patients: A Risk-Based Ophthalmologic Management.

Ocular immunology and inflammation
2026

Fifteen-day topical ketorolac tromethamine, with and without benzalkonium chloride, alters tear function, goblet cell density, and meibomian gland integrity in healthy cats.

Veterinary world
2026

Association Between Iris Manipulation during Phacovitrectomy for Retinal Detachment Repair and Proliferative Vitreoretinopathy.

Retina (Philadelphia, Pa.)
2026

Efficacy of adalimumab in chronic non-infectious anterior uveitis: a retrospective study.

International ophthalmology
2026

A case study of pars plana vitrectomy with scleral flaps covering a two-point sutured scleral-fixated intraocular lens in a tertiary care eye hospital.

Indian journal of ophthalmology
2026

Noninfectious uveitis: Management with biologic agents.

Indian journal of ophthalmology
2026

Racial Disparities Associated with Non-Infectious Anterior Uveitis and Concurrent Ocular Conditions: Results from a Large Multi-Institutional Research Network.

Ocular immunology and inflammation
2026

Visual Disturbance and Elevated Glutamic Acid Decarboxylase Antibody Levels as Manifestations of Central Nervous System Lymphoma.

Neurology India
2026

Systemic metastatic retinal lymphoma masquerading as granulomatous uveitis.

GMS ophthalmology cases
2026

Targeting CDH13 as a therapeutic strategy to mitigate pathological ocular angiogenesis.

Journal of translational medicine
2026

Integrated omics reveal the effects of vitamin D deficiency on gut microbiota and plasma metabolism in experimental autoimmune uveitis.

Journal of neuroinflammation
2026

Gut-derived hyodeoxycholate reprograms the spleen-eye immunometabolic axis to suppress autoimmune uveitis.

Cell death and differentiation
2026

Tubercular chorioretinitis mimicking sarcoidosis in a patient with celiac disease and erythema nodosum: A case report.

World journal of clinical cases
2026

miR-223-3p improves macrophage polarization balance and mitochondrial metabolism to ameliorate uveitis by orchestrating P65Lys310 acetylation through RBPJ/HDAC1 axis.

Cellular &amp; molecular biology letters
2026

CMV retinitis: the diagnostic challenges and long-term outcomes. The experience of tertiary eye center in Saudi Arabia.

Journal of ophthalmic inflammation and infection
2026

Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies.

RMD open
2026

Vitreous transcriptomic profiling reveals miR-4762 as a potential diagnostic biomarker and modulator of disease pathophysiology in Tubercular Uveitis.

Tuberculosis (Edinburgh, Scotland)
2026

Persistent Anterior Uveitis After Cataract Surgery in a Global Majority Population in North West London.

Ocular immunology and inflammation
2026

The Role of Plasminogen Activator Inhibitor-1 in Uveitis: Findings from Clinical and Experimental Studies.

Current eye research
2026

A case of uveitis and retinal vasculitis induced by varicella-zoster virus: vitrectomy treatment and literature review.

BMC ophthalmology
2026

Clinical phenotype and long-term damage in paediatric Behçet's disease: comparative performance of ISG, ICBD and PEDBD classification criteria in a retrospective endemic cohort.

RMD open
2026

Acute Retinal Necrosis Presenting with Exudative Retinal Detachment: Clinical Features and Outcomes.

Ocular immunology and inflammation
2026

Efficacy of pars plana vitrectomy for symptomatic vitreous floaters associated with Fuchs heterochromic iridocyclitis.

BMC ophthalmology
2026

Sterile Anterior Segment Inflammation Associated With Sulcus-Supported Phakic IOL Surgery.

Journal of refractive surgery (Thorofare, N.J. : 1995)
2026

Iberian Registry of Ocular Syphilis (IBERSOS) report 1: epidemiology, clinical spectrum and treatment outcomes of ocular syphilis in the Iberian Peninsula.

The British journal of ophthalmology
2026

Incidence and Prevalence of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis.

Retina (Philadelphia, Pa.)
2026

When adalimumab fails in childhood chronic uveitis: what comes next?

Expert opinion on biological therapy
2026

Case Report: Diverse pediatric phenotypes of RELA frameshift variants: comparison of two cases.

Frontiers in immunology
2026

Pigment loss and pseudo-albinism in Birdshot chorioretinitis.

Eye (London, England)
2026

MLGT: A multimodal graph attention network for virtual screening of anti-Uveitis drugs.

PloS one
2026

Anterior Uveitis in an HLA-B27 Positive Patient Following Influenza Vaccination.

International medical case reports journal
2026

Medication adherence rates in patients with ocular inflammatory disease.

Frontiers in medicine
2026

[Intraocular inflammation after intravitreal injection of second-generation anti-VEGF agents observed in a tertiary center over 12 months: What are the specific features?].

Journal francais d'ophtalmologie
2026

Uveitis as a Disguise - Masquerade Syndromes in the Modern Era.

Ocular immunology and inflammation
2026

One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Ophthalmology and therapy
2026

Relentless placoid chorioretinitis associated with Crohn's disease and secondary MEWDS: a case report.

American journal of ophthalmology case reports
2026

Ocular manifestations of STAT3 gain-of-function syndrome: A case of papillitis, retinitis, and retinal vasculitis.

American journal of ophthalmology case reports
2026

Incidence of Cataract Surgery and Postoperative Visual Acuity Outcomes in Patients with Vogt-Koyanagi-Harada Disease.

Ocular immunology and inflammation
2026

Risk Factors for Long COVID Among Individuals with Noninfectious Uveitis in a Large United States Claims Database.

Ocular immunology and inflammation
2026

Ocular syphilis: Clinical characteristics, HIV status, and outcomes in a 10-year case series from Türkiye.

International journal of STD &amp; AIDS
2026

Treatment adherence in chronic uveitis: What does the MARS-5 tell us?

BMC ophthalmology
2026

Detection of circulating immune complexes in feline leishmaniosis: first evidence and diagnostic implications.

Veterinary research communications
2026

Therapeutic Effect of Baicalin-Loaded Thermosensitive Liposomal Hydrogel in Autoimmune Uveitis.

ACS omega
2026

Bilateral Simultaneous Acute Angle-Closure Glaucoma Following Over-the-Counter Cold Medication.

Case reports in ophthalmological medicine
2026

Growth hormone-releasing hormone in retinal disorders and uveitis: an updated review.

International journal of ophthalmology
2026

Complications and challenges of refractive surgery.

Current opinion in ophthalmology
2026

Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien®) Intravitreal Injections: The "SAFAC" Study.

Ophthalmology and therapy
2026

Vogt-Koyanagi-Harada-like uveitis with severe hyalitis during treatment by anti-programmed death 1 antibody for lung cancer: a case report.

Journal of medical case reports
2026

Update on subthreshold micropulse laser treatment for retinal diseases: A narrative review.

Survey of ophthalmology
2026

Novel advances in juvenile idiopathic arthritis associated uveitis.

Arthritis research &amp; therapy
2026

Characterization of JIA subtypes, clinical features, treatment patterns, and early outcomes in Palestinian children: a retrospective cohort study.

Pediatric rheumatology online journal
2026

Advances and Challenges in Sulcus-Implanted Intraocular Lenses: A Comprehensive Narrative Review.

Ophthalmology and therapy
2026

Optic neuropathies induced by immune checkpoint inhibitors: A case series and systematic review of the literature.

European journal of cancer (Oxford, England : 1990)
2026

The Sleeping Wolf - Widefield OCT Angiography Revelations of Insidious Systemic Lupus Erythematous-Associated Retinal Vasculitis.

Retinal cases &amp; brief reports
2026

Ocular Involvement as a Key Marker of Systemic Disease in Dogs Naturally Infected with Leishmania infantum: Clinical, Laboratory, and Histopathological Insights.

Pathogens (Basel, Switzerland)
2026

Varicella-Zoster Virus and the Eye: Clinical Spectrum, Management, and Vaccination.

Pathogens (Basel, Switzerland)
2026

Prevalence of Polypoidal Choroidal Vasculopathy Beyond Recalcitrant Macular Neovasculopathies in a European AMD Cohort and Therapeutic Response to Brolucizumab.

Journal of clinical medicine
2026

Early Transcriptomic Response of Human Iris Stromal Cells During Herpes Simplex Virus Entry Reveals Interplay Between Cell Glycocalyx and Viral Exploitation.

International journal of molecular sciences
2026

Patterns of Inflammation in Experimental Autoimmune Uveitis and Their Correlation to Optical Coherence Tomography Findings in Human Uveitis.

International journal of molecular sciences
2026

Increased Risk of Incident Uveitis Among Patients with Psoriasis: A Nationwide Population-Based Cohort Study.

Diagnostics (Basel, Switzerland)
2026

Carbon Monoxide Therapy: Evidence and Prospects for Preventing and Treating Retinal Diseases.

Biomolecules
2026

Metastatic Intraocular Tumor Likely from Hepatocellular Carcinoma Mimicking Panuveitis.

Acta medica Okayama
2026

Atypical acute inflammatory reaction after intravitreal dexamethasone implant: a case of sterile endophthalmitis.

Archivos de la Sociedad Espanola de Oftalmologia
2026

Interpretable Deep Learning for OCT-Based Diagnosis of Vitreoretinal Lymphoma Versus Uveitis.

Translational vision science &amp; technology
2026

A Perplexing Plexopathy After Pembrolizumab Therapy in Early-Stage Triple-Negative Breast Cancer.

Current oncology (Toronto, Ont.)
2026

Metabolic checkpoints in the regulation of Th17 cells: implications for uveitis pathogenesis and therapy.

Frontiers in immunology
2026

Case Report: Vogt-Koyanagi-Harada syndrome complicated by secondary glaucoma: diagnostic insights and mechanistic correlations in uveitic ocular hypertension.

Frontiers in medicine
2026

Beyond the Skin: Granulomatous Uveitis Linked to Active Tattoo Inflammation.

Cureus
2026

Diagnostic significance of salivary and glandular siglec-5 in Sjögren disease and non-Sjögren sicca.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]
2026

Tackling the diagnosis of HA20 in children: challenges of a highly variable clinical and genetic spectrum.

RMD open
2026

Rate of posterior capsular opacification and complications of YAG capsulotomy in patients with uveitis.

Journal of cataract and refractive surgery
2026

[On the urgency of treating ophthalmic emergencies].

Die Ophthalmologie
2026

[Ocular rosacea : Clinical aspects, diagnostics, management and treatment].

Dermatologie (Heidelberg, Germany)
2025

Exophthalmos and Buphthalmos in Broiler Breeders Associated with Marek's Disease Virus.

Avian diseases
2026

Comparative Clinical Features, Vascular Complications, and Outcomes in CMV Retinitis: Pediatric vs HIV Positive and HIV Negative Adults.

Ocular immunology and inflammation
2026

Drug-Related Uveitis: A Real-World Study Based on the Food and Drug Administration Adverse Event Reporting System Database.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
2026

Characteristics Associated with Appointment No-Show at an Academic Uveitis Service.

Ocular immunology and inflammation
2026

Resurgence of Ocular Syphilis: HIV Co-Infection, Clinical Manifestations, and High-Risk Sexual Behaviour in an Indonesian Cohort.

Ocular immunology and inflammation
2026

Evaluation of concomitant peripheral arthritis in early axial spondyloarthritis: results from a 24 month follow-up (Italian arm of SPACE study).

Scandinavian journal of rheumatology
2026

Exploratory whole-exome sequencing identifies candidate DNA variants in Ocular Behcet disease: a pilot study from a Pakistani cohort.

Ophthalmic genetics
2026

Birdshot Chorioretinopathy with Cystoid Macular Oedema.

Klinische Monatsblatter fur Augenheilkunde
2026

Pan American League of Associations for Rheumatology: Recommendations for the Treatment of Oligoarticular Juvenile Idiopathic Arthritis.

Journal of clinical rheumatology : practical reports on rheumatic &amp; musculoskeletal diseases
2026

VKH-Like Syndrome in a Patient on Tofacitinib.

Journal of vitreoretinal diseases
2026

Evolving Consultation: Enhancing Ophthalmic Diagnostic Performance Using Large Language Model.

Ophthalmology science
2026

Protective effects of Shabyar on endotoxin-induced uveitis in male rats: Involvement of the JAK2/STAT3 and VEGF pathways.

Journal of ethnopharmacology
2026

Viral triggers and genetic predisposition in ocular autoimmunity: unraveling the breakdown of immune privilege and advancing targeted therapeutics.

Molecular aspects of medicine
2026

Accessibility and readability of Spanish and Portuguese-translated online information about common eye conditions: A cross-sectional content analysis study.

Journal of the National Medical Association
2026

Clinical Features and Treatment Outcomes of Patients with Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Series.

Ocular immunology and inflammation
2026

Assessment of the Prevalence and Characteristics of Hip Involvement in Spondyloarthritis: Results From a Rheumatology Outpatient Center.

Cureus
2026

Rates of Drug-Induced Uveitis: A Review by Medication Class.

Clinical ophthalmology (Auckland, N.Z.)
2026

Ocular Manifestations of Biopsy-Proven B Virus Infection with Central Nervous System Involvement.

JAMA ophthalmology
2026

Pattern of Uveitis in a Secondary Eye Care Center at Panipat, Haryana.

Clinical ophthalmology (Auckland, N.Z.)
2026

Scleral Fixation of Intraocular Lenses: Outcomes From MA60AC Intraocular Lens Fixation With a 10-0 Prolene Suture vs Akreos Intraocular Lens Fixation With a Polytetrafluoroethylene (Gore-Tex) Suture.

Journal of vitreoretinal diseases
2026

Ultrasound biomicroscopy findings in uveitic hypotony: a three-case report.

BMC ophthalmology
2026

Immunology of Uveitis - From Bench to Bedside.

Klinische Monatsblatter fur Augenheilkunde
2026

Rheumatologic Manifestations of Patients With Type B Insulin Resistance.

Arthritis care &amp; research
2026

The importance of patients' beliefs about biologic therapy in axial spondyloarthritis.

Postgraduate medicine
2026

Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial.

Trials
2026

Epidemiology of Uveitis and Extra-Uveal Inflammation in a Referral Center in Central Italy.

Ocular immunology and inflammation
2026

Evaluating nerve dysfunction in Behçet's disease: a study using corneal confocal microscopy and electromyography.

International ophthalmology
2026

Hazards of Malaysia's Favorite Sport: A Case Series of Badminton-Related Ocular Injuries at a Single Tertiary Center.

Cureus
2026

Epstein-Barr Virus-Associated Primary Vitreoretinal B-Cell Lymphoma in a Patient Receiving Tofacitinib and Methotrexate for Psoriatic Arthritis.

Ocular immunology and inflammation
2026

Endogenous Nocardia Nova Panophthalmitis Masquerading as Malignancy: A Clinicopathologic Report.

Retinal cases &amp; brief reports
2026

Impact of Socioeconomic Disadvantage on Clinical Outcomes of Inflammatory Eye Disease Patients Requiring Systemic Immunosuppression.

Ocular immunology and inflammation
2026

[Collection of aqueous humor samples for proteome analyses].

Die Ophthalmologie
2026

In-the-Bag Uveitis-Glaucoma-Hyphema Syndrome with Iris Chafing: Anterior Segment OCT.

Journal of cataract and refractive surgery
2026

Sequential Multiple-Organ Immune-Related Adverse Events during and after Pembrolizumab Therapy in Triple-Negative Breast Cancer: A Case Report.

Case reports in oncology
2026

Multicenter international cohort study of haploinsufficiency of A20 reveals novel genetic architecture and phenotypic evolution.

The Journal of allergy and clinical immunology
2026

Plasma metabolomics reveals distinct metabolic alterations and biomarkers of disease activity in HLA-B27-positive acute anterior uveitis.

Eye (London, England)
2026

Uveitis model in rabbit: Dexamethasone loaded PHBSA nanoparticles.

Experimental eye research
2026

Retinal and choroidal microcirculation in fuchs uveitis syndrome after caffeine intake assessed using OCTA.

Photodiagnosis and photodynamic therapy
2026

Combination of Methotrexate and Mycophenolate mofetil for Refractory Uveitis & Scleritis: A Case Series.

Retinal cases &amp; brief reports
2026

Novel CAPN5 mutation associated with bilateral retinal vasculopathy, peripheral non-perfusion, and a tractional retinal detachment in a 2-month-old girl.

Retinal cases &amp; brief reports
2026

Spontaneous Regression of a Retinal Mass With Epstein-Barr Virus-Positive and Cytomegalovirus-Positive Panuveitis in Methotrexate-Associated Lymphoproliferative Disorder.

Cureus
2026

Drug Rechallenge after Immune Checkpoint Inhibitor-Induced Inflammation and Optic Nerve Disorders.

Ocular oncology and pathology
2026

Assessing ChatGPT's Performance in Delineating Uveitis: An analysis of responses to real-world case presentations.

medRxiv : the preprint server for health sciences
2026

Targeted RNA Degradation by RIBOTACs: A Novel Therapeutic Avenue for Ophthalmic Diseases.

International journal of molecular sciences
2026

Clinical effectiveness of the 0.18 mg fluocinolone acetonide intravitreal implant for non-infectious uveitis-associated macular edema: a real-world study.

BMC ophthalmology
2026

Rosacea scleritis and sclero-uveitis; under recognised and over treated.

Journal of ophthalmic inflammation and infection
2026

Incidence and treatment patterns of acute retinal necrosis: a nationwide population-based cohort study.

The British journal of ophthalmology
2026

Clinical Features and Risk Factors for Chronic Syphilitic Uveitis.

Ocular immunology and inflammation
2026

NOD2-Related Multisystem Inflammatory Disorders and Recent Advances.

Current rheumatology reports
2026

Re: Chauhan et al.: Risk of giant cell arteritis among patients presenting with undifferentiated noninfectious uveitis (Ophthalmology. 2025;132:1180-1182).

Ophthalmology
2026

Chasing shadows: case series of six posterior segment manifestations of ocular tuberculosis.

AME case reports
2026

Idiopathic unilateral ocular vasculitis in a young adult: a case report on clinical course and steroid response.

Annals of medicine and surgery (2012)
2026

The Rusty Eye: Ocular Siderosis Masquerading as Chronic Anterior Uveitis.

Cureus
2026

Artesunate ameliorates experimental autoimmune uveitis by inhibiting the LCN2-STAT3 axis and suppressing microglial activation.

Redox report : communications in free radical research
2026

Atypical Cogan's syndrome is common among Japanese patients: A case report and literature review in Japan.

Internal medicine (Tokyo, Japan)
2026

Laboratory Workup in Pars Plana Diagnostic Vitrectomy: A Real-World Multidisciplinary Retrospective Case Series of Brazilian Patients with Uveitis.

Ocular immunology and inflammation
2026

Trematode induced ocular granuloma in children from South India.

Indian journal of ophthalmology
2026

Current perspective on infectious uveitis.

Indian journal of ophthalmology
2026

Interferon as a novel agent for management of macular edema: Where do we stand?

Indian journal of ophthalmology
2026

Masterclass- Axial and peripheral Spondyloarthritis: Screening, suspicion and referral in musculoskeletal clinical practice.

Musculoskeletal science &amp; practice
2026

Atypical Panuveitis in Disseminated Coccidioidomycosis.

Retinal cases &amp; brief reports
2026

The Probability of Detecting Sarcoidosis in Uveitis Patients with Intermittent Tattoo Swelling: A Retrospective Analysis.

Ocular immunology and inflammation
2026

Vogt-Koyanagi-Harada Disease in Paediatric Population: Case Series and Literature Review.

Ocular immunology and inflammation
2026

Risk Factors for Visual Impairment and Blindness Due to Non-Infectious Uveitis in Colombia: COL-UVEA Report 3.

Ocular immunology and inflammation
2026

Novel Combined Approach for Vision-Preserving Iridociliary Tumour Excision in a Small-Breed Dog: Contralateral Iris Excision With En-Bloc Scleral Resection.

Veterinary medicine and science
2026

Ozurdex® Implant Inside the Capsular Bag: A Report of a Rare Case.

Cureus
2026

Intravitreal implants for drug delivery: clinical efficacy, safety, and translational perspectives.

Expert opinion on drug delivery
2026

Treatment of a Large Cohort of Childhood Chronic Noninfectious Uveitis in a Multicentric Large Study: Adalimumab Versus Methotrexate as First-Line Therapy.

Arthritis &amp; rheumatology (Hoboken, N.J.)
2026

Beyond placoid: diverse clinical presentations and functional outcomes of acute syphilitic posterior placoid chorioretinopathy.

Eye (London, England)
2026

Artificial Intelligence in Uveitis: A 360-Degree Perspective.

Ocular immunology and inflammation
2026

An Atypical Presentation of Tubulointerstitial Nephritis With Uveitis (TINU) in an Older Patient Requiring Emergency Dialysis: A Case Report.

Clinical case reports
2026

Gut microbial alterations associated with the exacerbation of experimental autoimmune uveitis in PGRN-deficient mice.

Frontiers in immunology
2026

Clinical Presentation and Management of Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Series.

Cureus
2025

A Novel Multimodal Large Language Model for Interpreting Image-Based Ophthalmology Case Questions: Comparative Analysis of Multiple-Choice and Open-Ended Response.

Beyoglu eye journal
2025

Assessment of ocular manifestations in spondyloarthropathies: An observational study.

Bioinformation
2026

The CD74-MIF axis contributes to acute uveitic injury by upregulating proinflammatory cytokine secretion in murine cytomegalovirus intracameral infection mouse models.

Experimental eye research
2026

Clinical outcomes of fibrin glue assisted hemostasis in persistent intraoperative optic disc bleeding.

International journal of retina and vitreous
2026

Corneal and Pupillary Characteristics in Herpetic Anterior Uveitis: Insights from Topography, Specular Microscopy, and Pupillometry.

Ocular immunology and inflammation
2026

Topical mycophenolate for the treatment of uveitis-associated inflammation.

Journal of ophthalmic inflammation and infection
2026

Macrophage immunosenescence prolongs intraocular inflammation in aged mice via impaired induction of regulatory T cells.

bioRxiv : the preprint server for biology
Ver todos os 12.898 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Uveíte.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Uveíte

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Quantitative Assessment of Fluorescein Angiography Leakage via Deep Learning in Pediatric Uveitis: Correlation with Clinical Parameters.
    Ophthalmology science· 2026· PMID 41858681mais citado
  2. OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
    Ophthalmology science· 2026· PMID 41853570mais citado
  3. Microglia-independent rAAV-induced inflammation causes persistent ocular immune dysregulation rescued by S1P receptor modulation.
    Molecular therapy : the journal of the American Society of Gene Therapy· 2026· PMID 41832600mais citado
  4. Focus on Lactate and Lactylation Modification: The Potential Role in Ophthalmic Disease Treatment.
    International journal of molecular sciences· 2026· PMID 41828731mais citado
  5. Visual Disturbance and Elevated Glutamic Acid Decarboxylase Antibody Levels as Manifestations of Central Nervous System Lymphoma.
    Neurology India· 2026· PMID 41817073mais citado
  6. Risk Factors for Immune Recovery Uveitis in Patients with Cytomegalovirus Retinitis After Hematopoietic Stem Cell Transplantation.
    Ocul Immunol Inflamm· 2026· PMID 41996150recente
  7. QuantiFERON-TB gold test: a valuable diagnostic tool for tubercular uveitis in non-endemic regions.
    Infection· 2026· PMID 41995793recente
  8. WHEN TUBERCULIN STINGS: A CASE OF PANOPHTHALMITIS FOLLOWING TUBERCULIN SKIN TEST.
    Retin Cases Brief Rep· 2025· PMID 41995404recente
  9. Paradoxical Vitiligo Induced by Adalimumab in Ankylosing Spondylitis With Uveitis: Clinical Management and Therapeutic Considerations.
    Int J Rheum Dis· 2026· PMID 41995268recente
  10. Characteristics of Uveitis in European Tertiary Ophthalmology Centers: A Systematic Review and Meta-Analysis.
    Ocul Immunol Inflamm· 2026· PMID 41994897recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:98715(Orphanet)
  2. MONDO:0020283(MONDO)
  3. GARD:19549(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q280027(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Uveíte
Compêndio · Raras BR

Uveíte

ORPHA:98715 · MONDO:0020283
Prevalência
1-5 / 10 000
Ensaios
18 ativos
Prevalência
38.0 (Europe)
MedGen
UMLS
C0042164
Repurposing
2 candidatos
difluprednateglucocorticoid receptor agonist
rimexolone
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades